Clinical Trials Directory

We are doing this study as a means to collect and store samples and other data for future research on finding ways to treat cancer better.

We are doing this study to find the most effective, safe dose of an experimental drug called Bomedemstat (the study drug). We want to know how well this study drug works in people with PV.

We are doing this study to find out if an experimental drug called KTX-1001 (the study drug) is a safe and effective treatment for multiple myeloma. We want to identify the most appropriate dose and dosing schedule of the study drug for patients with multiple myeloma.

We are doing this study to find out if an experimental drug called KO-539 (study drug) is a safe and effective treatment for AML. We want to know if it might be beneficial for people with AML that is resistant to standard treatments.

We are doing this study to see if the study drugs, LBL-007 plus tislelizumab in combination with bevacizumab plus capecitabine, are safe and effective for treating metastatic or unresectable colorectal cancer.

We are doing this study to find out if an investigational drug called pirtobrutinib (LOXO-305) is a safe and effective treatment for CLL/SLL when it is given in combination with venetoclax and rituximab. The combination of venetoclax and rituximab is an approved therapy that is safe and effective for some people who did not respond to a first line of treatment or had their cancer progress after treatment. We want to know if adding LOXO-305 to the approved therapy will have better results.

We are doing this study to find out if an experimental drug called LYL845 (the study drug) is a safe and effective treatment for your cancer. The study drug is custom-made for each participant from their own tumor tissue.

We are doing this study to learn if a MRI can find changes in the spinal cord that relate to pain.